MedPath

A study to understand why the patients abandon treatment for cancer

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2022/09/046072
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adult patients ( >18 years) newly diagnosed with cancer (non-hematological tumors treated with a â??curativeâ?? intent or those in whom the expected survival is at least one year) who are willing to participate in the study and fulfilling the eligibility criteria within one week of initiation of treatment

Exclusion Criteria

1. Patients who have had any form of cancer-directed treatment prior to presentation to JIPMER

2. Patients who are planned only for supportive care without cancer-directed treatment

3. Patients who are planned for enrolment in clinical trials

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath